Free Trial

Mangoceuticals (MGRX) SEC Filings & 10K Form

Mangoceuticals logo
$2.19 -0.17 (-7.20%)
As of 03:46 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Mangoceuticals SEC Filings

DateFilerForm TypeView
08/04/2025
8:00 AM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2025
6:24 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2025
4:27 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2025
11:15 PM
Mangoceuticals (Filer)
Form EFFECT
06/19/2025
11:15 PM
Mangoceuticals (Filer)
Form EFFECT
05/23/2025
4:27 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2025
8:00 AM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2025
4:00 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
4:00 PM
Mangoceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/28/2025
4:00 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2025
8:00 AM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2025
4:29 PM
Mangoceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/19/2025
8:00 AM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2025
8:00 AM
Mangoceuticals (Filer)
Form DEF 14A
02/12/2025
7:00 AM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2025
4:25 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2025
3:46 PM
Mangoceuticals (Filer)
Form PRE 14A
01/31/2025
4:25 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2025
4:28 PM
GREENFIELD INVESTMENTS LTD. (Filed by)
Mangoceuticals (Subject)
Form SCHEDULE 13G
01/21/2025
3:30 PM
Isaac Antonios (Reporting)
Mangoceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/21/2025
3:30 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2025
3:30 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:30 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2024
3:30 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
4:30 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
4:15 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
4:04 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
4:06 PM
JOHNSTON EUGENE M (Reporting)
Mangoceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2024
7:00 AM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
4:00 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
7:00 AM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2024
4:10 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
4:15 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
7:30 AM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
4:25 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
6:30 AM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
3:30 PM
Mangoceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
11:15 PM
Mangoceuticals (Filer)
Form EFFECT
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MGRX) was last updated on 9/2/2025 by MarketBeat.com Staff
From Our Partners